Insulin Glargine
Also known as: Basaglar, Basaglar Tempo Pen, Insulin Glargine Max Solo U300, Insulin Glargine Solostar U300, Insulin Glargine-Yfgn U100, Lantus, Lantus Solostar, Rezvoglar, Semglee, Toujeo, Toujeo Max Solostr, Toujeo Solostar.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Package | Class |
|---|---|---|---|---|
| 100 UNIT/ML | Pen | $20.93 / mL | $313.94 / 15 ML box | Brand |
| 100 UNIT/ML | Vial | $16.06 / mL | $160.62 / 10 ML box | Brand |
| 300 UNIT/ML | (unspecified) | $91.27 / mL | — | Brand |
| 300 UNIT/ML | Pen | $91.33 / mL | $411.00 / 4.5 ML box | Brand |
| — | (unspecified) | $26.99 / mL | — | Generic |
| — | Pen | $4.42 / mL | $66.25 / 15 ML box | Generic |
| — | Vial | $6.11 / mL | $61.06 / 10 ML box | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates. Liquids, creams, and sprays are priced per mL or gram; a typical package may be a bottle or tube (size not set yet). Box prices are per full package where the size is known.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $613,875,257 gross for Insulin Glargine across 3,618,941 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$8,037,176 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS